AUDDIA INC. — Form 8-K
Filed October 22, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 87/100
What the filing says
Auddia amended senior unsecured bridge notes dated October 16, 2026 with four entities controlled by Dr. Jeffrey Thramann (Thramann Holdings LLC, LT350 LLC, Influence Healthcare LLC, Voyex LLC) to increase maximum funding commitments: Thramann Holdings from $360k to $420k (+$60k), LT350 from $400k to $1.9M (+$1.5M), Influence Healthcare from $590k to $900k (+$310k), and Voyex from $50k to $85k (+$35k). Total new commitment: $3.305M (up from $1.4M). Funding provides interim working capital pending merger closure that would make McCarthy Finney the public holding company with Auddia and Target Companies as subsidiaries.
Why this rating
Bridge funding of $3.3M is 127% of Auddia's $2.6M market cap—existential leverage for a micro-cap. Merger contingency and debt structure pose material dilution and financial distress risk.
Price action (we called it negative)
before filing · preread $0.93 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 22, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.